Microaerobic conditions enhance type III secretion and adherence of enterohaemorrhagic Escherichia coli to polarized human intestinal epithelial cells.
Advances in the understanding of the pathogenesis of enterohaemorrhagic Escherichia coli (EHEC) have greatly benefited from the use of human epithelial cell lines under aerobic conditions. However, in the target site of EHEC infection, the human intestine, conditions are microaerobic. In our study we used polarized human colon carcinoma cells in a vertical diffusion chamber system to investigate the influence of reduced apical oxygen levels on EHEC colonization. While apical microaerobiosis did not affect cell integrity and barrier function, numbers of adherent bacteria were significantly increased under low compared with high apical oxygen concentrations. In addition, expression and translocation of EHEC type III secreted (T3S) effector proteins was considerably enhanced under microaerobic conditions and dependent on the presence of host cells. Increased colonization was mainly mediated via EspA as adherence levels of an isogenic deletion mutant were not influenced by low oxygen levels. Other potential adherence factors (E. coli common pilus and flagella) were only minimally expressed under high and low oxygen levels. Addition of nitrate and trimethylamine N-oxide as terminal electron acceptors for anaerobic respiration failed to further increase bacterial colonization or T3S under microaerobiosis. This study indicates that EHEC T3S and colonization are enhanced by the microaerobic environment in the gut and therefore might be underestimated in conventional aerobic cell culture systems.
Schüller
Stephanie
S
Centre for Paediatric Gastroenterology, UCL Medical School, Royal Free Campus, London, UK. s.schuller@medsch.ucl.ac.uk
Phillips
Alan D
AD
D000332:Aerobiosis; D001422:Bacterial Adhesion; D045744:Cell Line, Tumor; D016764:Cell Polarity; D003470:Culture Media / Q000737:chemistry; D054324:Enterohemorrhagic Escherichia coli / Q000254:growth & development* / Q000378:metabolism; D004847:Epithelial Cells / Q000378:metabolism / Q000382:microbiology*; D004927:Escherichia coli Infections / Q000378:metabolism / Q000382:microbiology*; D029968:Escherichia coli Proteins / Q000378:metabolism; D010861:Fimbriae, Bacterial / Q000378:metabolism; D006801:Humans; D010100:Oxygen / Q000378:metabolism
D003470:Culture Media; D029968:Escherichia coli Proteins; D010100:Oxygen
Cell Microbiol. 2001 Oct;3(10):669-79
11580752
Cell. 1997 Nov 14;91(4):511-20
9390560
Infect Immun. 2005 Feb;73(2):1034-43
15664947
J Bacteriol. 2003 Jan;185(1):204-9
12486057
Microbiology (Reading). 2007 Feb;153(Pt 2):464-473
17259617
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4586-91
10200306
Infect Immun. 1999 May;67(5):2389-98
10225900
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15196-201
10611361
Mol Microbiol. 1998 Oct;30(1):147-61
9786192
J Bacteriol. 2007 Mar;189(6):2262-73
17220229
Cell Microbiol. 2009 Jan;11(1):121-37
19016776
Vet Microbiol. 2006 Mar 10;113(1-2):63-72
16337755
Appl Environ Microbiol. 2008 Feb;74(4):1087-93
18083855
EMBO J. 1998 Apr 15;17(8):2166-76
9545230
Microbes Infect. 2006 Jun;8(7):1851-8
16815721
Infect Immun. 1998 Apr;66(4):1680-7
9529098
Mol Cell Biochem. 2000 Dec;215(1-2):39-46
11204454
Infect Immun. 1997 Jul;65(7):2606-12
9199427
Infect Immun. 2002 Jul;70(7):3500-9
12065489
Int J Food Microbiol. 2009 May 31;131(2-3):224-32
19336271
J Clin Microbiol. 2004 Oct;42(10):4697-701
15472329
Mol Microbiol. 1998 Dec;30(5):911-21
9988469
Infect Immun. 1996 Mar;64(3):966-73
8641808
J Bacteriol. 2005 Apr;187(8):2881-9
15805534
Appl Environ Microbiol. 2008 May;74(9):2908-14
18310437
Lancet. 2005 Mar 19-25;365(9464):1073-86
15781103
Antonie Van Leeuwenhoek. 2008 Oct;94(3):455-61
18563621
Microbiology (Reading). 2009 Sep;155(Pt 9):2907-2918
19497950
J Bacteriol. 2007 Oct;189(20):7426-35
17693516
Res Microbiol. 1994 Jun-Aug;145(5-6):437-50
7855430
Infect Immun. 2004 Jun;72(6):3218-27
15155623
Infect Immun. 2004 Sep;72(9):5452-9
15322044
Proc Natl Acad Sci U S A. 1990 Jun;87(11):4304-8
2349239
Infect Immun. 1990 Jun;58(6):2014-6
1971262
Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10637-42
17563352
J Biol Chem. 2002 Sep 13;277(37):33978-86
12058029
Infect Immun. 1987 Jan;55(1):69-77
3539808
Infect Immun. 2007 Oct;75(10):4891-9
17698572
J Appl Microbiol. 1999 Jan;86(1):117-24
10030015
Mol Microbiol. 1998 May;28(3):463-74
9632251
Infect Immun. 1991 Jan;59(1):437-40
1987056